Navigation Links
MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
Date:5/19/2008

CHARLOTTE, N.C., May 19 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH), its physician partners and Good Samaritan Hospital, Dayton, Ohio, jointly announced today that the parties have completed the sale of Dayton Heart Hospital to Good Samaritan Hospital. Under terms of the transaction, Good Samaritan purchased substantially all of Dayton Heart Hospital's assets for $55.0 million.

Net proceeds to MedCath, after income tax expense related to the gain on sale and liquidation of net working capital retained by the hospital partnership, are anticipated to total approximately $32.0 million. MedCath will use the proceeds for general corporate purposes, including investment in other hospital projects.

Opened in 1999, Dayton Heart Hospital is a 47-bed hospital focused on providing cardiovascular care to the Dayton community. A member of the Premier Health Partners system, Good Samaritan Hospital (Dayton, Ohio) is a 577-bed, full-service teaching facility with a 75-year history that delivers best-in-care cardiovascular, cancer and orthopedics services. Recently, the Joint Commission awarded gold seal certifications to the Good Samaritan's outstanding heart failure, heart attack, breast cancer and artery bypass graft surgery programs. Additionally, HealthGrades, the leading independent quality monitoring organization in the country, named Good Samaritan as a recipient of its 2008 Distinguished Hospital Award for Clinical Excellence, which places it among the top 5 percent of hospitals nationwide.

"We've enjoyed our longstanding relationship with our physician partners in working jointly to provide quality cardiovascular care to the residents in Dayton and nearby communities," said O. Edwin French, MedCath's President and Chief Executive Officer. "We wish them and Good Samaritan continued success in servicing the healthcare needs of the local market."

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital in Kingman, Arizona. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties. Although management believes that these forward- looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Form 10-K filed with the Securities and Exchange Commission on December 14, 2007, a copy of which is available on the internet site of the Securities and Exchange Commission at http://www.sec.gov.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Names Parker to New Finance Post
2. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
3. MedCath Corporation Reports Second Quarter Earnings
4. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
5. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
6. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
7. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
8. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
9. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
10. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
11. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... The Industrial Designers Society of America (IDSA) ... awareness of the profession of industrial design (ID) and relaunching "What Is ID?" ... school students and counselors; parents; and the greater public. , Share details and photos ...
(Date:3/1/2017)... Philadelphia, Pennsylvania (PRWEB) , ... March 01, 2017 , ... ... the Bucci Law Firm, filed a civil sex abuse lawsuit in the Circuit Court ... adult males, who have only been identified by their initials. See L.B. and T.B. ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living and leading a healthy ... Go. , Time & Go app is the ultimate strategic compass that helps users ... management methods enable people to work smarter, not harder, that's why Time & Go ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... special pricing in the month of March for treatments aimed at tightening skin ... features use on Thermage skin tightening, with 30 percent off all Thermage face ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Marriage...God's Way: Key To One ... Key To One Flesh” is the creation of published author Cecilia Chiam, a writer ... Publishing, Cecilia Chiam‘s new book presents solutions to many marital problems with the guidance ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
(Date:3/1/2017)... 1, 2017  The Pharmaceutical Care Management Association (PCMA) ... vote to advance the nomination of Seema Verma ... Services Administrator: "The popular Medicare Part ... American health care. By offering an abundance of competing ... tools like pharmacy networks and home delivery, the program ...
(Date:3/1/2017)... -- The global  Intraoperative Neuromonitoring (IONM) market  is expected to reach ... Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in ... in a wide spectrum of surgeries. Continue Reading ... ... ...
Breaking Medicine Technology: